Previous studies from our research group have demonstrate lack of liver toxicity associated with other Fc-less constructs derived from the same anti-4-1BB moiety (10, 22), in contrast to the off-tumor toxicities observed in rodents treated with anti-4-1BB IgG. The gene discussed is TNFRSF9; the disease is neoplasm.